A phase II study of decitabine for the front-line treatment of older patients with acute myeloid leukemia

Trial Profile

A phase II study of decitabine for the front-line treatment of older patients with acute myeloid leukemia

Completed
Phase of Trial: Phase II

Latest Information Update: 17 May 2013

At a glance

  • Drugs Decitabine (Primary)
  • Indications Acute myeloid leukaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
    • 15 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
    • 08 Dec 2008 Results were presented at the 50th Annual Meeting of the American Society of Hematology (ASH).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top